Experimental use of cytosine arabinoside in congenital cytomegalovirus infection.
D000380:Agranulocytosis / Q000139:chemically induced; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D013921:Thrombocytopenia / Q000139:chemically induced; D014839:Vomiting
D003561:Cytarabine